Weight-adjusted versus fixed dose heparin thromboprophylaxis in hospitalized obese patients: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2021.03.030
Abstract: BACKGROUND Fixed dose unfractionated or low molecular weight heparin is the recommended treatment for venous thromboembolism (VTE) prevention in hospitalized patients. However, its efficacy has been questioned in obese population. Results of previous studies on… read more here.
Keywords: dose heparin; vte; weight; weight adjusted ... See more keywords
Type and dose of heparin in Covid‐19: Reply
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14870
Abstract: We thank the authors for their comments and feedback on the ISTH interim guidance. Hyper-coagulability is indeed a significant issue in COVID-19 and the haemostatic system is shifted markedly towards the procoagulant side in these… read more here.
Keywords: dose heparin; heparin covid; heparin; type dose ... See more keywords
Incidence of deep venous thrombosis in COVID-19 critically ill patients treated with intermediate-dose of heparin for thromboprophylaxis: The COVIDOP-DVT observational study
Sign Up to like & getrecommendations! Published in 2023 at "Vascular"
DOI: 10.1177/17085381231165083
Abstract: Introduction The high prevalence of deep vein thrombosis (DVT) in patients admitted to intensive care unit (ICU) for COVID-19-related acute respiratory distress syndrome (ARDS) would justify systematic screening of these patients or higher therapeutic dose… read more here.
Keywords: dose heparin; dvt; covid; intermediate dose ... See more keywords
In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j21-0019
Abstract: SOURCE CITATION Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial.… read more here.
Keywords: inpatients covid; risk inpatients; high risk; dose ... See more keywords